Trials / Completed
CompletedNCT00578331
Safety Study of Olopatadine Nasal Spray
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 890 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olopatadine 0.6% nasal spray | 2 sprays each nostril twice daily |
| DRUG | Placebo Nasal Spray | 2 sprays each nostril twice daily |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2007-12-21
- Last updated
- 2017-10-31
- Results posted
- 2010-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00578331. Inclusion in this directory is not an endorsement.